Tag: astellas-pharma
-
Astellas, Vical herpes vaccine fails mid-stage study
(Reuters) – Japan’s Astellas Pharma Inc and San Diego-based Vical Inc said their experimental herpes vaccine failed a mid-stage study involving certain kidney transplant patients. Vical’s shares was down about 18 percent in light premarket trading on Monday. The DNA vaccine, ASP0113, is designed to prevent cytomegalovirus (CMV) disease in patients receiving a renal transplant…
-
Cycling-Data leak boosts Froome, puts Wiggins in spotlight
By Alan Baldwin LONDON, Sept 19 (Reuters) – Chris Froome’s credibility as triple Tour de France champion has only been boosted by the hacking of his private medical information, according to a South African physiologist who carried out tests on the Briton last year. Jeroen Swart, in an interview with the Cycling Tips website, suggested,…